Wen Su
Impact in
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics
-
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 3
-
- Cancer-related molecular mechanisms research 2
- Co-authors
- Zhi‐Jun Sun (5 shared papers)Zhigang Xu (4 shared papers)Wei Qiu (3 shared papers)Xianbin Ma (3 shared papers)Jiming Xu (2 shared papers)Yufan Wang (5 shared papers)Hongyu Yang (5 shared papers)Qi‐Chao Yang (2 shared papers)
In The Last Decade
Wen Su
13 papers receiving 379 citations
Peers
Comparison fields: 5 of 30
- Biomedical Engineering 172
- Biomaterials 38
- Cancer Research 33
- Molecular Biology 149
- Oncology 42
Countries citing papers authored by Wen Su
This map shows the geographic impact of Wen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Su more than expected).
Fields of papers citing papers by Wen Su
This network shows the impact of papers produced by Wen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Su. The network helps show where Wen Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Wen Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 104 | |
| 2 | 2021 | 61 | |
| 3 | 2022 | 56 | |
| 4 | 2022 | 45 | |
| 5 | 2019 | 42 | |
| 6 | 2018 | 30 | |
| 7 | 2023 | 20 | |
| 8 | 2019 | 14 | |
| 9 | 2018 | 7 | |
| 10 | 2019 | 5 | |
| 11 | 2019 | 3 | |
| 12 | 2018 | 2 | |
| 13 | 2026 | 1 |
About Wen Su
Wen Su is a scholar working on Oncology, Cancer Research, Biomedical Engineering, Immunology and Biomaterials, having authored 13 papers that have together received 390 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Circular RNAs in diseases (3 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), Cancer-related molecular mechanisms research (2 papers), Advancements in Battery Materials (1 paper), Immune cells in cancer (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Biomedical Engineering (172 citations), Biomaterials (38 citations), Cancer Research (33 citations), Molecular Biology (149 citations) and Oncology (42 citations). Wen Su has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Zhi‐Jun Sun, Zhigang Xu, Wei Qiu, Xianbin Ma, Jiming Xu, Yufan Wang, Hongyu Yang, Qi‐Chao Yang, Shuo Wang and Peng Xue. Their work appears in journals such as Advanced Functional Materials, Journal of Cellular and Molecular Medicine, International Immunopharmacology, Advanced Materials and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.